Y-mAbs Therapeutics Inc (YMAB)
Y-mAbs Therapeutics Market Cap: 509.04M for May 17, 2024
Market Cap Chart
Historical Market Cap Data
Date | Value |
---|---|
May 17, 2024 | 509.04M |
May 16, 2024 | 520.01M |
May 15, 2024 | 534.49M |
May 14, 2024 | 518.69M |
May 13, 2024 | 534.93M |
May 10, 2024 | 538.88M |
May 09, 2024 | 564.77M |
May 08, 2024 | 597.24M |
May 07, 2024 | 755.22M |
May 06, 2024 | 756.54M |
May 03, 2024 | 752.59M |
May 02, 2024 | 756.97M |
May 01, 2024 | 723.62M |
April 30, 2024 | 667.45M |
April 29, 2024 | 680.03M |
April 26, 2024 | 645.37M |
April 25, 2024 | 651.07M |
April 24, 2024 | 670.81M |
April 23, 2024 | 673.01M |
April 22, 2024 | 665.11M |
April 19, 2024 | 663.79M |
April 18, 2024 | 657.79M |
April 17, 2024 | 662.61M |
April 16, 2024 | 663.93M |
April 15, 2024 | 653.84M |
Date | Value |
---|---|
April 12, 2024 | 630.16M |
April 11, 2024 | 641.56M |
April 10, 2024 | 604.73M |
April 09, 2024 | 617.01M |
April 08, 2024 | 633.67M |
April 05, 2024 | 634.11M |
April 04, 2024 | 638.49M |
April 03, 2024 | 632.35M |
April 02, 2024 | 647.26M |
April 01, 2024 | 709.97M |
March 28, 2024 | 711.82M |
March 27, 2024 | 722.32M |
March 26, 2024 | 687.30M |
March 25, 2024 | 687.74M |
March 22, 2024 | 710.50M |
March 21, 2024 | 741.58M |
March 20, 2024 | 678.11M |
March 19, 2024 | 651.84M |
March 18, 2024 | 602.37M |
March 15, 2024 | 643.52M |
March 14, 2024 | 656.66M |
March 13, 2024 | 693.43M |
March 12, 2024 | 704.37M |
March 11, 2024 | 721.88M |
March 08, 2024 | 771.35M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
The Cooper Companies Inc | 19.34B |
Puma Biotechnology Inc | 197.54M |
Humacyte Inc | 753.80M |
NovaBay Pharmaceuticals Inc | 4.487M |
Palatin Technologies Inc | 32.27M |
Market Cap Related Metrics
PS Ratio | 5.995 |
Price to Book Value | 5.132 |
Price | 11.56 |
Earnings Yield | -4.22% |